BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12913937)

  • 1. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
    Valsakumar AK; Valappil UC; Jorapur V; Garg N; Nityanand S; Sinha N
    J Rheumatol; 2003 Aug; 30(8):1793-8. PubMed ID: 12913937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of Takayasu's arteritis: personal experience.
    de Franciscis S; Serra R; Luongo A; Sabino G; Puzziello A
    Ann Vasc Surg; 2007 Nov; 21(6):754-60. PubMed ID: 17512164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
    de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
    Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Takayasu's arteritis: underestimated cause of hypertension].
    Cybulska I; Makowiecka-Cieśla M; Florczak E
    Przegl Lek; 2001; 58(6):490-4. PubMed ID: 11816738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.
    Park MC; Lee SW; Park YB; Lee SK
    Rheumatology (Oxford); 2006 May; 45(5):545-8. PubMed ID: 16352633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limited role of MRI in long-term follow-up of patients with Takayasu's arteritis.
    Eshet Y; Pauzner R; Goitein O; Langevitz P; Eshed I; Hoffmann C; Konen E
    Autoimmun Rev; 2011 Dec; 11(2):132-6. PubMed ID: 21946651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
    Mok CC; Ying KY; Mak A; To CH; Szeto ML
    Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.
    Park MC; Lee SW; Park YB; Chung NS; Lee SK
    Scand J Rheumatol; 2005; 34(4):284-92. PubMed ID: 16195161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Takayasu's arteritis--case report and review of the literature].
    Schurch MA; Gerster JC
    Rev Med Suisse Romande; 2000 Oct; 120(10):777-80. PubMed ID: 11109906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 16-year survey of Takayasu's arteritis in a tertiary Belgian center.
    Ruige JB; Van Geet C; Nevelsteen A; Verhaeghe R
    Int Angiol; 2003 Dec; 22(4):414-20. PubMed ID: 15153827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity.
    Tripathy NK; Sinha N; Nityanand S
    J Rheumatol; 2003 Sep; 30(9):2023-6. PubMed ID: 12966610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble endothelial cell adhesion molecules and their relationship to disease activity in Takayasu's arteritis.
    Tripathy NK; Chandran V; Garg NK; Sinha N; Nityanand S
    J Rheumatol; 2008 Sep; 35(9):1842-5. PubMed ID: 18597403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients.
    Maksimowicz-McKinnon K; Clark TM; Hoffman GS
    Arthritis Rheum; 2007 Mar; 56(3):1000-9. PubMed ID: 17328078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Takayasu's arteritis--course, diagnosis and long term results of treatment].
    Cybulska I
    Pol Arch Med Wewn; 1994 Jun; 91(6):451-60. PubMed ID: 7971466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Takayasu's arteritis: A study of 104 Italian patients.
    Vanoli M; Daina E; Salvarani C; Sabbadini MG; Rossi C; Bacchiani G; Schieppati A; Baldissera E; Bertolini G;
    Arthritis Rheum; 2005 Feb; 53(1):100-7. PubMed ID: 15696576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
    Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
    Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.
    Massacesi L; Parigi A; Barilaro A; Repice AM; Pellicanò G; Konze A; Siracusa G; Taiuti R; Amaducci L
    Arch Neurol; 2005 Dec; 62(12):1843-7. PubMed ID: 16344342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 12 in Takayasu's arteritis: plasma concentrations and relationship with disease activity.
    Verma DK; Tripathy NK; Verma NS; Tiwari S
    J Rheumatol; 2005 Dec; 32(12):2361-3. PubMed ID: 16331764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment.
    Tso E; Flamm SD; White RD; Schvartzman PR; Mascha E; Hoffman GS
    Arthritis Rheum; 2002 Jun; 46(6):1634-42. PubMed ID: 12115196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.